Objective: Economic evaluations such as cost-effectiveness and cost-utility
analyses generally fail to incorporate elements of intangible costs and be
nefits, such as anxiety and discomfort associated with the screening test a
nd diagnostic test, as well as the magnitude of utility associated with a r
eduction in the risk of dying from cancer. This paper seeks to include all
costs and effects incurred by introducing mammography screening through the
application of discrete ranking modeling.
Methods: In the present analysis, 207 women were interviewed and asked to r
ank, according to priority, a number of alternative breast cancer screening
setups. The alternative programs varied with respect to number of tests pe
rformed, risk reduction obtained, probability of a false-positive outcome,
and extent of copayment. Using discrete ranking modeling, the stated prefer
ences were analyzed and the relative weighting of the program attributes id
entified. For a range of hypothetical breast cancer programs, relative util
ities and corresponding willingness-to-pay estimates were derived.
Results: A comparison of cost and willingness to pay for each of the progra
ms suggested that net benefits are maximized when screening person aged 50-
74 years biennially. More intensive screening produces lower or similar lev
els of utility at a higher cost.
Conclusion: Discrete ranking modeling can aid decision making by identifyin
g inferior healthcare programs, i.e., programs that are more costly but les
s beneficial.